40 mg
Trade Name
Speranta
Film-coated tablet
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Indicated for the extended adjuvant treatment of adult patients with early-stage hormone receptor positive HER2-overexpressed/amplified breast cancer and who completed adjuvant trastuzumab-based therapy less than one year ago.